BioPharmaSpec
Andrew Reason has over 25 years of experience in the biopharmaceutical industry. Andrew is currently the CEO and MD of BioPharmaspec, a contract research organization specializing in structural characterization and physico-chemical analysis of biopharmaceuticals. Prior to their current role, Andrew was a Visiting Professor at the University of Warwick and a consultant at Acumentia Consulting Ltd, where they provided expertise in food, beverage, nutrition, and healthcare solutions. Andrew also held various management positions at SGS, including UK Business Manager Life Science Services and Managing Director of M-Scan Limited and M-Scan GmbH. Andrew began their career as a Post-Doctoral Research Assistant at the University of London.
Andrew Reason obtained a B.Sc (Hons) in Biochemistry from the University of Wales, College Swansea from 1985 to 1988. Andrew then pursued higher education and earned a Ph.D in Biochemistry from the University of London (Imperial College) between 1989 and 1992.
This person is not in any teams
This person is not in any offices
BioPharmaSpec
BioPharmaSpec is a UK and US based CRO providing structural and physicochemical protein characterization services. We help our clients get their biopharmaceutical products into clinical trials more cost effectively and quickly. Our technical expertise includes the structural characterization and physicochemical analysis of recombinant biopharmaceuticals such as biosimilars and biobetters, monoclonal antibodies, Antibody Drug Conjugates (ADCs), blood circulating hormones, gene therapy products and oligonucleotide therapeutics. Using state-of-the-art Chromatographic and Mass Spectrometric instrumentation and methods, BioPharmaSpec applies expertise built up over 45 years of pioneering research, to assist clients in a number of protein characterization methods including Primary Amino Acid Sequencing, N and C terminal sequencing, Amino Acid Analysis, Peptide Mapping, Disulfide Bridge analysis, Glycan analysis and Higher Order Structure of proteins. Our analytical data helps you choose the best cell clone, provide batch to batch comparisons or perform biosimilar testing for biosimilarity and comparability studies. With BioPharmaSpec's support, solid development decisions can be made based on quality analytical data and experience.